Child with Cancer (NUR 320) – Comprehensive Exam Study Notes

Epidemiology & Etiology of Childhood Cancer

  • Second leading cause of death in the pediatric population (after unintentional injuries)
  • Etiology is largely unknown
    • Current theory: multifactorial interaction among
    • Genetic alterations
    • Environmental exposures (radiation, toxins, viral triggers, etc.)
    • Immune‐system dysfunction or inadequate tumor surveillance
  • Psychosocial / developmental overlay
    • Diagnosis collides with critical growth stages ⇒ regression, altered body image, school disruption
    • Family-centered care is ethically imperative; parents/guardians are primary partners in decision-making
    • Family stressors: financial strain, anticipatory grief, caregiver role strain, cultural/spiritual questions

Fundamental Tumor Biology

  • Neoplasm = any new growth or tumor
  • Tumors classified as benign or malignant
    • Benign: localized, usually encapsulated, non-invasive
    • Malignant:
    • Life-threatening potential
    • Invasion of contiguous tissue
    • Metastasis via blood, lymph, or CSF
    • Cells poorly differentiated / anaplastic

Clinical Presentation – Pediatric Specifics

  • Pediatric cancers often present with covert, nonspecific complaints ("the cold that lingers")
  • Typical red-flag signs & symptoms
    • Mass or swelling
    • Purpura / unexplained bruising
    • Pallor or anemia-related fatigue
    • \downarrow weight (unintentional)
    • Persistent or projectile vomiting
    • Recurrent or low-grade fevers
    • Bone or joint pain, limp
    • Headache (especially a.m.)
    • Lymphadenopathy (firm, non-tender nodes)
    • Gait, personality, or balance changes
    • General fatigue / malaise
  • NCLEX-style recall: fatigue, headache, weight loss, lymphadenopathy are classic; polydipsia is NOT

Diagnostic Work-Up

  • Laboratory studies
    • CBC: pancytopenia, leukocytosis, or isolated cytopenias
    • Chemistry: electrolyte shifts, \uparrow uric acid, \downarrow albumin
  • Procedures
    • Bone-marrow aspiration/biopsy (posterior iliac crest; prone with pillow)
    • Lumbar puncture (evaluate CNS involvement; intrathecal chemo route)
  • Imaging modalities
    • X-ray, ultrasound, CT, MRI, PET
  • Pathology / flow cytometry for definitive cell typing

Nursing Considerations for Invasive Procedures

  • Obtain informed consent; developmentally appropriate explanations (use play/visual aids)
  • Sedation for young or anxious children; allow parental presence
  • Positioning: prone with small pillow under hips for marrow aspiration
  • Coping techniques: singing, counting, deep breathing during needle entry (<10 sec discomfort)
  • Post-procedure
    • Pressure dressing if platelet count <50{,}000/\text{mm}^3
    • Monitor VS, puncture site for hemorrhage or infection

Treatment Modalities Overview

  • Surgery (curative, debulking, biopsy)
  • Radiation therapy (external beam, fractionated doses)
  • Chemotherapy (multi-agent protocols)
  • Biologic / immunotherapy (e.g., monoclonal antibodies, CAR-T)
  • Complementary & alternative modalities (massage, art therapy) – evaluate evidence & safety
  • Hematopoietic stem-cell transplant (HSCT) – autologous or allogeneic

Central Venous Access Devices (CVADs)

  • Long-term routes: Port-a-Cath, PICC, tunneled catheters
  • Access with non-coring (Huber) needle; sterile technique imperative
  • Teaching: flushing schedule, infection-prevention, swimming restrictions, when to seek help

Chemotherapy Essentials

  • Mechanism: cytotoxic to rapidly dividing cells ⇒ high collateral on GI mucosa, hair follicles, marrow
  • Routes: PO, IV, IM, SQ, intrathecal
  • Setting: inpatient, outpatient clinic, or home infusion
  • Common adverse effects
    • Bone-marrow suppression: thrombocytopenia, neutropenia, anemia
    • Nausea / vomiting (anticipatory, acute, delayed)
    • Mucositis / stomatitis
    • Alopecia
    • Photosensitivity, fatigue, diarrhea
  • Nursing priorities
    • Reverse isolation & neutropenic precautions (ANC <500/\text{mm}^3)
    • Strict infection control; no fresh flowers, raw produce
    • Transfusion support (PRBCs, platelets)
    • Bleeding & injury prevention; soft toothbrushes, no rectal temps
    • Nutrition: high-calorie, high-protein; TPN if necessary
    • Pain & nausea management (opioids, antiemetics BEFORE chemo)
    • Sun protection, activity clustering, developmentally appropriate play

Preparing & Administering Chemotherapy (OSHA High-Alert)

  • Verify height & weight ⇒ calculate body-surface area (BSA) m2\text{m}^2
  • Double-check dose with 2nd RN, cross-reference protocol (COG, institutional)
  • Review CBC within 4848 h; hold if counts below threshold
  • Confirm CVAD patency; new peripheral IV for vesicants
  • Have emergency meds & extravasation kits at bedside
  • Don appropriate PPE per OSHA/NIOSH

Radiation Therapy – Key Points

  • Delivered in fractionated doses to limit toxicity
  • Acute side-effects
    • Fatigue
    • Dermatitis / skin breakdown in radiation field
    • Alopecia in field
    • Nausea / vomiting, anorexia
    • Myelosuppression
  • May also see late effects months–years later (endocrine dysfunction, secondary malignancies)

Stem-Cell / Bone-Marrow Transplant (HSCT/BMT)

  • Stem-cell sources: bone marrow, peripheral blood, cord blood
  • Autologous (self) vs allogeneic (matched donor)
  • Infused cells migrate to marrow ⇒ restore hematopoiesis
  • Common acute toxicities: mucositis, profuse diarrhea, fevers, epistaxis
  • Core nursing care
    • Strict neutropenic isolation; positive-pressure room if available
    • GVHD surveillance (rash, liver dysfunction, diarrhea)
    • Antirejection / immunosuppressant management
    • Nutritional, emotional, and developmental support

Pediatric Oncologic Emergencies

  • Tumor Lysis Syndrome (TLS)
    • Rapid lysis ⇒ release of K+K^+, phosphate, uric acid; \downarrow calcium
    • Risk of renal failure; maintain aggressive hydration, allopurinol/rasburicase, monitor labs & urine output
  • Hyperleukocytosis (> 100×109/L100\times10^9/\text{L}) ⇒ viscosity, stroke risk
  • Superior Vena Cava (SVC) Syndrome ⇒ facial/upper-body edema, respiratory compromise
  • Spinal-Cord Compression ⇒ back pain, motor loss, bladder dysfunction
  • Disseminated Intravascular Coagulation (DIC) ⇒ bleeding & microthrombi; support with blood products, treat trigger

General Acute Side Effects Across Therapies

  • Infection / sepsis
  • Hemorrhage
  • Anemia & fatigue
  • Nausea / vomiting (anticipatory, acute, delayed)
  • Altered nutrition & weight loss
  • Mucositis / ulcerations of GI tract
  • Neurotoxicity / peripheral neuropathies
  • Hemorrhagic cystitis (e.g., cyclophosphamide metabolite acrolein) ⇒ MESNA prophylaxis, hydration
  • Steroid-related: mood swings, hyperglycemia, cushingoid appearance

Acute Leukemias

  • Malignancy of marrow & lymph tissues ⇒ “liquid tumors”
  • Most common childhood cancer (<1515 yrs)
  • Pathophysiology: uncontrolled proliferation of immature blasts crowding healthy cells ⇒ pancytopenia

Acute Lymphoblastic Leukemia (ALL)

  • Accounts for majority; 55-yr disease-free survival >85%85\%
  • Diagnostics
    • CBC: pancytopenia, \uparrow lymphocytes
    • Bone-marrow aspirate: 25%\geq25\% lymphoblasts (confirmatory)
    • LP: evaluate CNS spread
    • Flow cytometry: B- vs T-cell lineage
  • Clinical staging (I–IV) by node & organ involvement (diagram review)
  • Therapy: multi-phase chemotherapy per Children’s Oncology Group (induction, consolidation, maintenance); potential HSCT
  • Focused Nursing Issues
    • Infection control (ANC monitoring)
    • Hemorrhage & bruising surveillance, nose-bleed management
    • Nutrition: high-calorie, antiemetics, weight tracking
    • Psychosocial: alopecia preparation, school re-entry facilitation

Lymphomas

  • Malignancies of lymphoid tissue
  • Two main entities
    • Hodgkin Lymphoma (HL)
    • Typically localized, single node chain
    • Reed-Sternberg cells pathognomonic
    • Non-Hodgkin Lymphoma (NHL)
    • Rapid, diffuse, often mediastinal mass
  • “B-symptoms”: night sweats, fever, >10\% weight loss
  • Painless, firm lymphadenopathy; hepatosplenomegaly; abdominal pain (NHL)
  • Treatment: risk-adapted chemo ± radiation; monitor TLS risk

Overview of Solid Tumors

  • Brain & CNS tumors
  • Neuroblastoma
  • Bone & muscle tumors (Osteosarcoma, Ewing sarcoma, Rhabdomyosarcoma)
  • Wilms tumor (nephroblastoma)
  • Retinoblastoma
  • Germ-cell & hepatic tumors

Brain Tumors

  • Most common solid pediatric tumor
  • Presentation
    • Early-morning headache, vomiting
    • Abnormal neuro exam; cranial nerve deficits
    • \uparrow intracranial pressure (ICP): papilledema, behavior change, decreased pulse pressure
  • Diagnostics: MRI preferred; CT, PET, LP (cautious), tissue biopsy
  • Management: surgical resection, chemo, targeted radiation
  • Post-op Nursing
    • Neuro checks, ICP control, positioning, fluid balance, comfort
    • Family emotional support & rehabilitation planning

Neuroblastoma

  • Arises from sympathetic chain (neural crest)
  • Often diagnosed as abdominal mass; can metastasize (bone, skin, orbit – “raccoon eyes”)
  • Symptoms: protuberant abdomen, limping, jerks, eyelid droop, facial edema
  • Diagnostics: biopsy, CT/MRI, catecholamine metabolite (HVA/VMA) elevations
  • Treatment: multimodal – chemo, surgery, radiation, HSCT, immunotherapy
  • Nursing: pain control, peri-op care, mobility support, parental coping

Bone & Muscle Tumors

  • Osteosarcoma
    • Peak adolescence; distal femur > prox tibia > prox humerus
    • Pain, swelling, decreased ROM
  • Ewing Sarcoma
    • Flat bones (pelvis, ribs, vertebrae)
    • Systemic symptoms (fever, weight loss)
  • Rhabdomyosarcoma
    • Soft-tissue tumor from mesenchyme (<1010 yrs common)
  • Multidisciplinary diagnosis (imaging, biopsy)
  • Treatment: limb-sparing surgery, amputation (osteosarcoma), chemo, radiation
  • Nursing: body-image counseling, prosthetic training, pain & function restoration

Wilms Tumor (Nephroblastoma)

  • Most frequent renal malignancy
  • Classic sign: painless abdominal mass; do NOT palpate vigorously (risk of rupture & seeding)
  • Metastasis commonly to lungs
  • Diagnostics: CT/MRI, UA, labs; staging I–V
  • Treatment: nephrectomy, chemo ± radiation
  • Pre-op: gentle handling, blood-pressure control; Post-op: output, infection, education on solitary kidney care

Retinoblastoma

  • Malignancy of retinal cell layer; >90\% diagnosed <5 yrs
  • Hallmark: leukocoria (“cat’s-eye” reflex) in photos, absent red reflex
  • Other: strabismus, vision loss, orbital inflammation
  • Diagnostics: fundoscopic exam under sedation, ocular US, CT/MRI
  • Treatment: chemo, focal radiation, cryotherapy; enucleation if advanced
  • Nursing: family preparation for prosthesis, genetic counseling (RB1 mutation)

Other Tumors

  • Germ-cell tumors: gonadal/extragonadal (testes, ovaries, sacrococcyx, mediastinum); surgical resection is cornerstone
  • Liver tumors
    • Hepatoblastoma (infants/young) & Hepatocellular carcinoma (5–15 yrs)
    • Surgery primary; transplant consideration

Survivorship & Late Effects

  • Overall long-term survival now >80%80\%
  • Late effects
    • Secondary malignancies (e.g., AML after etoposide)
    • Endocrine: growth hormone deficiency, infertility
    • Cardiac: anthracycline-induced cardiomyopathy
    • Neurocognitive impairment, psychosocial challenges
  • Lifelong, risk-based follow-up
    • Screening, surveillance, health-promotion education (diet, exercise, smoking avoidance)
  • Role of nurse: transition planning, advocacy, health-literacy reinforcement

Patient & Family Education Principles

  • Continuous dialogue: diagnosis comprehension, treatment phases, expected side effects
  • Skills teaching: CVAD care, medication administration, infection warning signs
  • Encourage participation & shared decision-making
  • Provide written & digital resources; connect with support groups, school liaison
  • Address ethical considerations: assent, fertility preservation, advance directives in older adolescents

Ethical, Philosophical, & Practical Highlights

  • Informed consent & child assent evolve with developmental stage
  • Balance cure with quality of life; palliative care integration when appropriate
  • Cultural sensitivity in discussing prognosis, complementary therapies
  • Financial toxicity & healthcare disparity awareness

Quick Reference – Numerical Pearls

  • ALL 55-yr DFS >85\%
  • Neutropenia cutoff: ANC <500/\text{mm}^3
  • Platelet precaution threshold: <50{,}000/\text{mm}^3
  • Hyperleukocytosis: WBC >100\times10^9/\text{L}
  • Majority of retinoblastoma cases present <5<5 yrs; >90%>90\% cured if localized

Mnemonic Aids

  • “CHILD CANCER” for warning signs (Children’s Oncology Group mnemonic):
    • Continued, unexplained weight loss
    • Headaches with early-morning vomiting
    • Increased swelling / persistent pain (bones, joints)
    • Lump or mass (abdomen, neck, etc.)
    • Development of whitish color behind pupil
    • Constant infections
    • Aches in bones, joints, back
    • Neurologic changes (balance, gait)
    • Constant fever
    • Excessive bruising, bleeding
    • Recurrent / persistent nausea

Summary

  • Pediatric oncology nursing demands holistic care: biomedical precision + psychosocial scaffolding.
  • Early recognition, protocol-driven treatment, meticulous supportive care, and family partnership yield high cure rates and improved lifelong outcomes.